Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

BS194

Copy Product Info
😃Good
Catalog No. T7698Cas No. 1092443-55-4

BS194 is as a potent cyclin-dependent protein kinases (CDKs) inhibitor.

BS194

BS194

Copy Product Info
😃Good
Purity: 99.85%
Catalog No. T7698Cas No. 1092443-55-4
BS194 is as a potent cyclin-dependent protein kinases (CDKs) inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$73In StockIn Stock
5 mg$179In StockIn Stock
10 mg$278In StockIn Stock
25 mg$473In StockIn Stock
50 mg$678-In Stock
100 mg$948-In Stock
1 mL x 10 mM (in DMSO)$253In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

BS194 AI Summary
BS194 exhibits a range of bioactivities, notably being a potent multi-targeted kinase inhibitor. It demonstrates inhibitory effects on various enzymes, including CDKs (cyclin-dependent kinases), MAPKs (mitogen-activated protein kinases), and other kinases, with competitive reversible inhibition. The most significant inhibition is observed against CDK2 (IC50 = 3.0 nM) and CDK5 (IC50 = 30.0 nM). The compound shows antiproliferative activity against various human cell lines such as MCF7, MCF10A, HCT116, A549, and HepG2, with specific cytotoxicity IC50 values of 300.0 nM for MCF7 cells and 1000.0 nM for HepG2 cells. It also demonstrates antitumor activity in xenograft mouse models and inhibits the proliferation of Plasmodium falciparum (DD2) with a potency of 8407.1 nM. Additionally, BS194 exhibits good metabolic stability, solubility, and oral bioavailability in mouse models, making it a potential candidate for developing new anticancer and antimalarial therapies..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
BS194 is as a potent cyclin-dependent protein kinases (CDKs) inhibitor.
Targets&IC50
CDK7:250 nM, CDK1:30 nM, CDK9:90 nM, CDK5:30 nM, CDK2:3 nM
Chemical Properties
Molecular Weight385.46
FormulaC20H27N5O3
Cas No.1092443-55-4
SmilesC(C)(C)C1=C2N(C(NCC3=CC=CC=C3)=CC(N[C@H]([C@@H](CO)O)CO)=N2)N=C1
Relative Density.1.33 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 14.3 mg/mL (37.1 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5943 mL12.9715 mL25.9430 mL129.7151 mL
5 mM0.5189 mL2.5943 mL5.1886 mL25.9430 mL
10 mM0.2594 mL1.2972 mL2.5943 mL12.9715 mL
20 mM0.1297 mL0.6486 mL1.2972 mL6.4858 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BS194 | purchase BS194 | BS194 cost | order BS194 | BS194 chemical structure | BS194 formula | BS194 molecular weight